home All News open_in_new Full Article
ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced Metastatic Cancer
today 2 w. ago attach_file Science
attach_file
Politics
attach_file
Science
attach_file
Other
attach_file
Other
attach_file
Economics
attach_file
Politics
attach_file
Economics
attach_file
Other
attach_file
Economics
attach_file
Culture
ID: 2466567694